Luliconazole

Luliconazole
Clinical data
Trade names	Luzu, Luzarn, Lulicon, LULY, Zyluli,Luris
Routes of; administration	Topical
ATC code	D01AC18 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Protein binding	>99%[1]
Identifiers
	IUPAC name (2E)-[(4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene](1H-imidazol-1-yl)acetonitrile;
CAS Number	187164-19-8;
PubChem CID	3003141;
ChemSpider	2273807;
UNII	RE91AN4S8G;
CompTox Dashboard (EPA)	DTXSID3048607 ;
Chemical and physical data
Formula	C14H9Cl2N3S2
Molar mass	354.27 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl;
	InChI InChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1; Key:YTAOBBFIOAEMLL-REQDGWNSSA-N;

Luliconazole, trade names Luzu among others, is an imidazole antifungal medication. As a 1% topical cream, It is indicated for the treatment of athlete's foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum[2] and Epidermophyton floccosum.[1]

References

"LUZU (luliconazole) Cream, 1%. Full Prescribing Information" (PDF). Valeant Pharmaceuticals North America LLC. Retrieved 1 October 2015.
"FDA approves luliconazole for tinea pedis". November 19, 2013. Archived from the original on 16 January 2014. Retrieved 14 January 2014.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.